ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,637Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 546

$862K Total Retail Price of All Prescriptions

Rank: 7 out of 546

580 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 13,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 652 611 1 5
LEVOTHYROXINE SODIUM 589 533 2 3
WARFARIN SODIUM 553 435 3 13
SERTRALINE HCL 510 489 4 14
METOPROLOL TARTRATE 477 445 5 6
DONEPEZIL HCL 471 450 6 31
TRAMADOL HCL 465 455 7 19
RISPERIDONE 424 373 8 47
SIMVASTATIN 320 247 9 2
MIRTAZAPINE 318 294 10 51
TRAZODONE HCL 312 296 11 25
LISINOPRIL 304 271 12 1
NAMENDA 250 248 13 60
AMLODIPINE BESYLATE 228 222 14 9
POTASSIUM CHLORIDE 205 187 15 30
OMEPRAZOLE 198 191 16 4
LIDODERM 195 193 17 73
TAMSULOSIN HCL 179 149 18 35
OXYCODONE HCL 169 89 S2 19 15
CITALOPRAM HBR 164 151 20 21
ISOSORBIDE MONONITRATE ER 162 155 21 32
CYMBALTA 159 101 22 37
HYDROCHLOROTHIAZIDE 157 127 23 7
PREDNISONE 150 146 24 29
METOPROLOL SUCCINATE 148 136 25 17
FENTANYL 146 117 S2 26 50
CARBIDOPA-LEVODOPA 140 140 27 76
ATORVASTATIN CALCIUM 135 120 28 11
METFORMIN HCL 133 78 29 10
JANUVIA 122 83 30 79
LANTUS 122 73 30 46
KLOR-CON M20 119 118 32 57
ATENOLOL 118 118 33 12
SPIRIVA 115 112 34 28
OLANZAPINE 113 86 35 103
QUETIAPINE FUMARATE 109 104 36 72
ADVAIR DISKUS 105 103 37 20
IPRATROPIUM-ALBUTEROL 103 99 38 90
GABAPENTIN 100 75 39 16
CIPROFLOXACIN HCL 94 81 40 84
ESCITALOPRAM OXALATE 93 84 41 66
KLOR-CON M10 92 89 42 118
LEVETIRACETAM 91 78 43 95
NYSTATIN 91 71 43 97
CARVEDILOL 89 89 45 56
PANTOPRAZOLE SODIUM 87 82 46 18
DIVALPROEX SODIUM 85 78 47 78
BACLOFEN 84 28 48 86
NYSTOP 82 69 49 145
LOSARTAN POTASSIUM 77 76 50 24
NITROFURANTOIN MONO-MACRO 76 70 51 215
FLUOXETINE HCL 76 63 51 39
ROPINIROLE HCL 72 68 53 64
ALLOPURINOL 69 67 54 41
GLIPIZIDE 68 52 55 44
NOVOLOG 67 55 56 142
LEVOFLOXACIN 66 60 57 167
TRANSDERM-SCOP 62 0 58 224
DIGOXIN 62 53 58 62
FAMOTIDINE 60 60 60 53
LATANOPROST 58 58 61 173
RAMIPRIL 57 57 62 155
PRAMIPEXOLE DIHYDROCHLORIDE 57 57 62 149
SPIRONOLACTONE 57 48 62 82
CARBAMAZEPINE 56 56 65 120
CLOPIDOGREL 55 55 66 77
PROMETHAZINE HCL 52 40 R 67 119
HALOPERIDOL 52 52 67 102
PAROXETINE HCL 50 48 69 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.